It has finally been confirmed that once you get double jabbed with the COVID-19 vaccines, you will never again be able to acquire full natural immunity against Covid variants – or possibly any virus.
This is revealed in COVID-19 vaccine surveillance report by the U.K Health Security Agency.
In its Week 42 surveillance report, the agency on page 23 admitted that “N antibody levels appear to be lower in people who acquire infection following two doses of vaccination.” It goes on to explain that this antibody drop is basically permanent.
What’s this mean?
We know the vaccines do not stop infection or transmission of the virus (in fact, the report shows elsewhere that vaccinated adults are now being infected at much HIGHER rates than the unvaccinated).
READ ALSO: Experts linked 26-year old man’s death to Pfizer COVID vaccine
What the British are saying is they are now finding the vaccine interferes with your body’s innate ability after infection to produce antibodies against not just the spike protein but other pieces of the virus.
Specifically, vaccinated people don’t seem to be producing antibodies to the nucleocapsid protein, the shell of the virus, which are a crucial part of the response in unvaccinated people.
In the long term, people who take the vaccine will be far more vulnerable to any mutations in the spike protein that might come along, even if they have already been infected and recovered once, or more than once.
The unvaccinated, meanwhile, will procure lasting, if not permanent, immunity to all strains of the alleged virus after being infected with it naturally even just once.
Meanwhile, eight cases of myocarditis, or heart inflammation, in children 5 to 11 years old who got the Pfizer-BioNTech COVID vaccine were reported to the Centers for Disease Control and Prevention (CDC), the agency said during a Dec. 16 meeting.
READ ALSO: Movie star drags ABC to court over forced COVID vaccine mandate
The CDC said there had been 3,233 reports to VAERS of adverse events among 5- to 11-year-olds, including 14 reports of myocarditis, five reports with follow-up in progress, nine reports with follow-up information obtained and eight reports of myocarditis that met the CDC’s working case definition, including four males and five females.
According to Pfizer, 1,403 cardiovascular AESIs, 932 hematologic, 3,600 musculoskeletal, 501 neurologic and 3,674 “other” serious AESIs all occurred with a median time of onset of 24 hours or less from vaccination.
The 275 strokes and 449 cases of facial paralysis reported occurred with a median time of onset of two days from vaccination.
Pfizer’s estimated incidence of potential vaccine fatality, 1 in 11,079, is approximately twice that reported in VAERS. Given that the potential vaccine fatalities in this document have been passively reported, we can assume the actual incidence is higher.